BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9861458)

  • 1. Identification and partial characterization of three calcium- and zinc-independent gelatinases constitutively present in human circulation.
    Makowski GS; Ramsby ML
    Biochem Mol Biol Int; 1998 Dec; 46(5):1043-53. PubMed ID: 9861458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of equine matrix metalloproteinase 2 and 9; and identification of the cellular sources of these enzymes in joints.
    Clegg PD; Burke RM; Coughlan AR; Riggs CM; Carter SD
    Equine Vet J; 1997 Sep; 29(5):335-42. PubMed ID: 9306058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of 72 kDa and 92 kDa type IV collagenases from human giant-cell tumor of bone.
    Rao VH; Bridge JA; Neff JR; Schaefer GB; Buehler BA; Vishwanatha JK; Pollock RE; Nicolson GL; Yamamoto M; Gokaslam ZL
    Clin Exp Metastasis; 1995 Nov; 13(6):420-6. PubMed ID: 7586800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of fluorometric and zymographic methods as activity assays for stromelysins and gelatinases.
    Quesada AR; Barbacid MM; Mira E; Fernández-Resa P; Márquez G; Aracil M
    Clin Exp Metastasis; 1997 Jan; 15(1):26-32. PubMed ID: 9009103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and identification of proteinases and proteinase inhibitors synthesized by temporomandibular joint disc cells.
    Kapila S; Lee C; Richards DW
    J Dent Res; 1995 Jun; 74(6):1328-36. PubMed ID: 7629341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.
    Schwartz JD; Shamamian P; Monea S; Whiting D; Marcus SG; Galloway AC; Mignatti P
    Surgery; 1998 Aug; 124(2):232-8. PubMed ID: 9706143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble factor(s) released from neutrophils activates endothelial cell matrix metalloproteinase-2.
    Schwartz JD; Monea S; Marcus SG; Patel S; Eng K; Galloway AC; Mignatti P; Shamamian P
    J Surg Res; 1998 Apr; 76(1):79-85. PubMed ID: 9695744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of latent matrix metalloproteinase 9 to fibrin: activation via a plasmin-dependent pathway.
    Makowski GS; Ramsby ML
    Inflammation; 1998 Jun; 22(3):287-305. PubMed ID: 9604716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the activities of matrix metalloproteinases 2, 8, and 9 by chlorhexidine.
    Gendron R; Grenier D; Sorsa T; Mayrand D
    Clin Diagn Lab Immunol; 1999 May; 6(3):437-9. PubMed ID: 10225852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status.
    Mäkelä M; Salo T; Uitto VJ; Larjava H
    J Dent Res; 1994 Aug; 73(8):1397-406. PubMed ID: 8083435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of gelatinases/type IV collagenases in jaw cysts.
    Teronen O; Salo T; Konttinen YT; Rifkin B; Vernillo A; Ramamurthy NS; Kjeldsen L; Borregaard N; Hietanen J; Sorsa T
    J Oral Pathol Med; 1995 Feb; 24(2):78-84. PubMed ID: 7745546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of matrix metalloproteinases in human urine: alterations during adolescence.
    Thrailkill KM; Kumar S; Rosenberg CK; Auten KJ; Fowlkes JL
    Pediatr Nephrol; 1999 Apr; 13(3):223-9. PubMed ID: 10353410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of metalloproteinase-like activities in barnacle (Balanus amphitrite) nauplii.
    Mannello F; Canesi L; Faimali M; Piazza V; Gallo G; Geraci S
    Comp Biochem Physiol B Biochem Mol Biol; 2003 May; 135(1):17-24. PubMed ID: 12781969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a serum gelatinase associated with the occurrence of cerebral aneurysms as pro-matrix metalloproteinase-2.
    Todor DR; Lewis I; Bruno G; Chyatte D
    Stroke; 1998 Aug; 29(8):1580-3. PubMed ID: 9707196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva.
    Golub LM; Sorsa T; Lee HM; Ciancio S; Sorbi D; Ramamurthy NS; Gruber B; Salo T; Konttinen YT
    J Clin Periodontol; 1995 Feb; 22(2):100-9. PubMed ID: 7775665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison, characterization, and identification of proteases and protease inhibitors in epididymal fluids of domestic mammals. Matrix metalloproteinases are major fluid gelatinases.
    Métayer S; Dacheux F; Dacheux JL; Gatti JL
    Biol Reprod; 2002 May; 66(5):1219-29. PubMed ID: 11967181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human collagenase activity by antisense oligonucleoside methylphosphonates.
    Delong RK; Miller PS
    Antisense Nucleic Acid Drug Dev; 1996; 6(4):273-80. PubMed ID: 9012863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of gelatinases with soluble and immobilized fetuin and asialofetuin.
    Ochieng J; Warfield P; Green B
    Arch Biochem Biophys; 1995 Sep; 322(1):250-5. PubMed ID: 7574683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer.
    Wojtowicz-Praga S; Low J; Marshall J; Ness E; Dickson R; Barter J; Sale M; McCann P; Moore J; Cole A; Hawkins MJ
    Invest New Drugs; 1996; 14(2):193-202. PubMed ID: 8913840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cleavage site specificity of gelatinases A and B using collagenous peptides.
    Xia T; Akers K; Eisen AZ; Seltzer JL
    Biochim Biophys Acta; 1996 Apr; 1293(2):259-66. PubMed ID: 8620038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.